NeuroMolecular Medicine · 2014 · 39 citations · 27 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyMolecular OncologyAngiogenesis In CancerCancer ImmunotherapyCentral Nervous System Tumor PharmacotherapyGlioblastomaPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsGlioblastoma AngiogenesisGlioblastoma Drug TherapyGlioblastoma ImmunotherapyGlioblastoma Targeted TherapyGlioblastoma Tumor Biology
27
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations
Medicine, Oncology, Pharmacology +17
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Clinical Cancer Research · 2007 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Christian Fischer, Bart Jonckx, Massimiliano Mazzone et al. · Cell · 2007 · 788 citations · Full text
Medicine, Oncology, Pharmacology +14